Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about GSK

Recent news which mentions GSK

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Why Is Sierra Oncology (SRRA) Stock Up Today?
Tickers ATRS GILD GSK HALO
Tags HALO GILD SRRA
From InvestorPlace
Sierra Oncology Stock Is Soaring: Here's Why
Tickers GSK SRRA
Tags GSK Small Cap Benzinga
From Benzinga
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
Tickers AFMD ALZN ATRS CRDF
Tags Benzinga Small Cap HALO
From Benzinga
Why Sierra Oncology Stock Is Soaring Today
Tickers GILD GSK SRRA
Tags GSK SRRA Market News
From Motley Fool
GlaxoSmithKline Scoops Up Rare Cancer-Focused Sierra Oncology In $1.9B Cash Deal
Tickers GSK SRRA
Tags Trading Ideas M&A Market News
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Tickers AGRX ALZN ATRS BPTH
Tags CTIC BPTH HSTO
From InvestorPlace
GlaxoSmithKline to buy Sierra Oncology for $1.9 billion
Tickers GSK SRRA
Tags SRRA UK:GSK GSK
From MarketWatch
Germany Inks COVID-19 Vaccine Deal With CureVac, GSK Until 2029
Tickers CVAC GSK
Tags News Biotech CVAC
From Benzinga
Watch For Continued Gains In Shares Of GlaxoSmithKline PLC (GSK)
Tickers GSK
Tags Partner Content GSK Benzinga
From Benzinga
This Exciting Biotech Stock Could Be Your Next 10-Bagger
Tickers GSK ME REGN
Tags Recent Press Releases GSK ME
From Motley Fool
3 Pharmaceutical Stocks With Awesome Futures
Tickers GSK MRNA NVAX PFE
Tags NVAX Market News PFE
From Motley Fool
3 Things About Pfizer That Smart Investors Know
Tickers ABBV AZN BMY GSK
Tags GSK JNJ BMY
From Motley Fool
What Is RSV, And Why Is Pfizer Paying Up To $525M For Treatment Candidates?
Tickers AZN GSK MRNA PFE
Tags Benzinga GSK ReViral
From Benzinga
Why Did FDA Pull Authorization For GSK-Vir's COVID-19 Therapy? Read Here
Tickers GSK VIR
Tags Briefs COVID/19 Coronavirus GSK
From Benzinga
BA.2 subvariant of omicron accounted for almost 94% of global cases in latest week in latest sign of how dominant it has become
Tickers BNTX GSK LLY MRK
Tags UK:GSK REGN LLY
From MarketWatch
3 CEOs to Invest In
Tickers ANTM AXSM AZN GH
Tags NVS IMCR GS
From Motley Fool
Why Shares of Vir Biotechnology Rose 20.4% This Week
Tickers GSK VIR
Tags Market News GSK VIR
From Motley Fool
CureVac - GSK Start Dosing In Next-Gen COVID-19 Vaccine Candidate Trial
Tickers CVAC GSK
Tags Phase 1 Trial News Biotech
From Benzinga
EMA Starts Review Of Sanofi-GlaxoSmithKline's COVID-19 Vaccine
Tickers GSK NVAX SNY
Tags News Biotech NVAX
From Benzinga
WHO urges countries to keep up COVID-19 testing and surveillance as the virus is still a global pandemic
Tickers ADGI CVAC GSK
Tags CVAC GSK ADGI
From MarketWatch
The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict
Tickers ADGI ADMP AFMD AMLX
Tags TSHA AFMD IKT
From Benzinga
Omicron BA.2 Variant Represents More Than 50% COVID-19 Cases, Says CDC Estimates: WSJ
Tickers AZN BNTX GSK JNJ
Tags Market News PFE JNJ
From Benzinga
FDA Approves ViiV Healthcare's Cabenuva For Virologically Suppressed Adolescents With HIV
Tickers GSK JNJ PFE
Tags Biotech News Market News
From Benzinga
Biden Administration Proposes $82B In Spending For Future Pandemics Preparedness
Tickers AZN BNTX GSK JNJ
Tags General BNTX MRNA
From Benzinga
FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant
Tickers GILD GSK LLY MRK
Tags LLY Briefs COVID/19 Coronavirus
From Benzinga
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
Tickers ACMR AMGN BABA BGNE
Tags NVS DCPH WB
From InvestorPlace
Are These 2 Rivals Beating Pfizer and Moderna?
Tickers AZN BNTX CVAC GSK
Tags CVAC NVAX AZN
From Motley Fool
Which Company Has the Biggest COVID Program? The Answer Isn't Moderna.
Tickers AZN GRFS GSK JNJ
Tags AZN NVAX LLY
From Motley Fool
These 3 Stocks Aren't Large Caps Yet, but They Each Could Make $1 Billion in Sales in 2022
Tickers BNTX CLOV GSK PEN
Tags PFE Market News CLOV
From Motley Fool
Drug makers, Scientists Working For Long COVID Treatments: Reuters
Tickers AXLA GSK HGEN MRNA
Tags AXLA Market News PFE
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.